So, we are adding materials, but I do not know what the hot stuff is. I know that the cell lines are in great demand, although I do not know which ones. The molecular materials, such as the clones, were hot for a while, and then slowed down.
DR. KYRPIDES: A very quick question. It is about the bacteria culture collections from which, if I am not mistaken, number about 15,000 or 20,000.
DR. SIMIONE: Yes, I think that number is close. It is 18,000 on the slides.
DR. KYRPIDES: For how many cultures do you really know what it is, in the sense that you have genomic sequencing?
DR. SIMIONE: I can tell you we do that, but not for the whole 18,000. As with my answer to the previous question, we are going to focus on those that are needed by the scientific community. Now, most of them had been characterized in some way when they came in, but that was prior to the genomic sequencing. We have that capability now, but there is no way we can go back. The issue is the cost; that is it would not be cost effective.
DR. KYRPIDES: Half or more than half?
DR. SIMIONE: I do not know the answer. I could find out for you though, because somebody at the ATCC knows the answer.